• Privacy policy
  • T&C’s
  • About Us
    • FAQ
  • Contact us
  • Guest Content
  • TLE
  • News
  • Politics
  • Opinion
    • Elevenses
  • Business
  • Food
  • Travel
  • Property
  • JOBS
  • All
    • All Entertainment
    • Film
    • Sport
    • Tech/Auto
    • Lifestyle
    • Lottery Results
      • Lotto
      • Set For Life
      • Thunderball
      • EuroMillions
No Result
View All Result
The London Economic
SUPPORT THE LONDON ECONOMIC
NEWSLETTER
The London Economic
No Result
View All Result
Home Lifestyle Health

Common painkillers ‘could promote potentially fatal superbug’

Researchers have identified a link between severe Clostridium difficile - or C.diff - infections and use of NSAIDs, or non-steroidal anti-inflammatory drugs, which include aspirin and ibuprofen

SWNS by SWNS
2019-01-08 13:18
in Health, Lifestyle
FacebookTwitterLinkedinEmailWhatsapp

Taking popular over the counter painkillers could make people more susceptible to a potentially fatal superbug, warns a new study.

Researchers have identified a link between severe Clostridium difficile – or C.diff – infections and use of NSAIDs, or non-steroidal anti-inflammatory drugs.

Common NSAIDs include aspirin and ibuprofen.

It has been previously shown that people treated with antibiotics are at heightened risk of C.diff because those drugs disturb the microbial balance of the gut

The new findings, published in the journal mBio, provide evidence for a connection between NSAIDs and C.diff, as well as an explanation of the underlying biological mechanism.

Researchers say that a better understanding of how NSAIDs affect the severity of C. diff infections could inform the development of future treatments.

The bacterial infection can affect the bowel and cause diarrhoea. The infection most commonly affects people who have recently been treated with antibiotics and can spread easily to others.

C Diff infections are unpleasant and can cause serious bowel problems and can even prove fatal for frail older people.

Leader of the new study Professor David Aronoff, a microbiologist and infectious diseases expert at Vanderbilt University in the United States, said: “We are always trying to think of modifiable risk factors for the disease.”

RelatedPosts

Reform’s Darren Grimes ‘left red faced’ after police deny urging him away from local surgeries 

How Quickly Can I Get a Doctor’s Appointment in London?

People are celebrating the anniversary of the ‘least accurate thing anyone ever wrote about Brexit’

The Happiness Hormones: What They Are and How to Get More of Them

The researchers followed two groups of antibiotic-treated mice for one week after infection with C.diff. One group had been treated with an NSAID called indomethacin prior to infection, and the other hadn’t.

Only about 20 per cent of the mice treated with the NSAID survived to the end of the observation period, compared to about 80 per cent of the mice that hadn’t been exposed to the NSAID.

Prof Aronoff and his colleagues determined that even brief exposure to the NSAID prior to C.diff inoculation increased the severity of infections and shortened survival.

Further cellular and genetic analyses revealed that the NSAID exposure altered the gut microbiota and depleted the production of prostaglandins, hormone-like substances known to play an important role in gastrointestinal health.

The researchers said that their observations align with previous studies reporting that NSAIDs can cause or exacerbate an inflammatory disease called colitis, also by inhibiting the body’s production of prostaglandins.

In the new study, the researchers conclude that NSAID-driven changes worsened C.diff infections by impairing epithelial cells – the main defence system in the intestine against infectious taxa – and by disturbing the normal immune response.

They studied the impact of only one NSAID, indomethacin, but Prof Aronoff believes the findings might extend to other common NSAIDs, including ibuprofen and aspirin, since they all have roughly the same biological mechanism.

He added: “Ultimately, these new results might guide how we treat people with C.diff, particularly with pain management.

“Right now, it’s too early for our results to guide clinical care, but they should be a stimulus for future studies.”

By Stephen Beech

Subscribe to our Newsletter

View our  Privacy Policy and Terms & Conditions

About Us

TheLondonEconomic.com – Open, accessible and accountable news, sport, culture and lifestyle.

Read more

SUPPORT

We do not charge or put articles behind a paywall. If you can, please show your appreciation for our free content by donating whatever you think is fair to help keep TLE growing and support real, independent, investigative journalism.

DONATE & SUPPORT

Contact

Editorial enquiries, please contact: [email protected]

Commercial enquiries, please contact: [email protected]

Address

The London Economic Newspaper Limited t/a TLE
Company number 09221879
International House,
24 Holborn Viaduct,
London EC1A 2BN,
United Kingdom

© The London Economic Newspaper Limited t/a TLE thelondoneconomic.com - All Rights Reserved. Privacy

No Result
View All Result
  • Home
  • News
  • Politics
  • Lottery Results
    • Lotto
    • Set For Life
    • Thunderball
    • EuroMillions
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • JOBS
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Privacy policy
  • Contact us

© The London Economic Newspaper Limited t/a TLE thelondoneconomic.com - All Rights Reserved. Privacy

← Millionaire found herself in court after throwing a road sign at a Range Rover ← Archaeologists discover rare collection of decapitated Roman skeletons
No Result
View All Result
  • Home
  • News
  • Politics
  • Lottery Results
    • Lotto
    • Set For Life
    • Thunderball
    • EuroMillions
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • JOBS
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Privacy policy
  • Contact us

© The London Economic Newspaper Limited t/a TLE thelondoneconomic.com - All Rights Reserved. Privacy

-->